U.S. stocks took a loss for most of their morning gains on Monday, which were brought down by biotechs after U.S. Democratic presidential candidate Hillary Clinton stated she would announce a plan to stop “price gouging” for specialty drugs. Luckily Progressive Care Inc (OTCMKTS:RXMD), Embarr Downs Inc (OTCMKTS:EMBR), and Wee-Cig International Corp (OTCMKTS:WCIG) were not affected by the decreases in stock caused by presidential candidate Hillary Clinton.
Wee-Cig International Corp (OTCMKTS:WCIG) Wee-Cig International Corporation is involved in designing, developing, manufacturing, and marketing e-cigarettes and vaporizers across the globe. Its products facilitate consumers to vaporize dried herbs, such as mullein, raspberry leaves, cat nip, and sage, which help to quit smoking and ease stress, as well as for inflamed or infected lungs. Wee-Cig International Corporation (WCIG) reports that in the past few months the Company has initiated the release of two new vapor products, the Wee-True and Wee-Vape as well as a silicon container sold to marijuana shops called the Wee-Blockz.
Embarr Downs Inc (OTCMKTS:EMBR), through its subsidiaries, works with purchasing, selling, and racing thoroughbreds in the United States. It also focuses obtaining and renovating single-family and multi-family properties. In addition, the company offers consulting services to organizations in many different industries; and develops various gourmet food products. For the month of September EMBR has seen 242.86% increase making them a penny stock to watch for potential investment options.
Progressive Care Inc (OTCMKTS:RXMD) Progressive Care, Inc., through its subsidiary, Pharmco, LLC, offers prescription medicine to people and institutions in south Florida. The company runs a retail pharmacy that deals in the sale of anti-retroviral medications and related patient care management; the sale and rental of reliable medical equipment (DME), such as hospital beds, oxygen supplies, power wheelchairs, scooters, walkers, and various related equipment and accessories; and the supply of various prescription medications to long term care facilities. In the first 3 weeks of August RXMD saw an increase of 92.02% making them an ideal small cap stock to see profitable gains depending on investments from investors.